Premium
Alternative Therapies for Neonatal Autoimmune Thrombocytopenia
Author(s) -
Ovali Fahri,
Samanci Nedim,
Ermiş Bahri,
Akdoǧan Zeliha,
Daǧoǧlu Türkan
Publication year - 1998
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1046/j.1423-0410.1998.7430198.x
Subject(s) - medicine , antibody , autoimmune thrombocytopenia , intravenous immunoglobulins , pediatrics , immunology
Objective: This study was performed to test whether corticosteroids were superior to intravenous immunoglobulins (IVIG) in the treatment of neonatal autoimmune thrombocytopenia (NAT). Methods: All cases received IVIG, and unresponsive cases received corticosteroids. Results: Of 7 babies who received IVIG, only 1 responded. The 6 remaining cases received corticosteroids therafter, and all of them responded well to this therapy. Conclusions: Corticosteroids may be more effective than IVIG in NAT.